IMS Health buys analytics company TTC

By Admin
IMS Health said it has acquired benchmarking solutions and analytics company TTC that helps life science companies around the world plan for and negoti...

IMS Health said it has acquired benchmarking solutions and analytics company TTC that helps life science companies around the world plan for and negotiate costs of clinical trials.

The leading provider of information, services and Analytics Company will integrate its evidence-based, anonymized patient and treatment outcomes insights with TTC’s comprehensive cost drawn from companies that conduct nearly 80% of all the commercial clinical studies.

Philadelphia-based TTC offers its clients a robust set of clinical trial benchmarks, budgeting and negotiating tools to enhance the speed, efficiency and cost-effectiveness of their trial planning and management activities.

The benchmarking solutions firm maintains the world’s largest clinical grant benchmarking and negotiation database namely GrantPlan. It also serves 17 of the top 20 pharmaceutical companies and eight of the ten largest contract research companies.

Andrew Kress, Senior Vice President, Healthcare Value Solutions, IMS, said, “This acquisition marks an important step in further expanding IMS’s capabilities in the pharma R&D space.” Mr. Kress also said, “This combination of TTC’s portfolio and IMS information assets will fuel ongoing innovation, enabling clients to base vital budgeting and negotiation decision on real-world data and benchmarks.”

TTC’s benchmark data and budgeting services will be available through IMS’s clinical trial optimization unit, part of the company’s Healthcare Value Solutions business, the news reports said.

Harold Glass, PhD, TTC President said, “We’re extremely pleased to join the IMS team.” Mr. Glass also said, “Our clients are actively seeking more data and analytics to guide their decision making and drive improvements in a process that today is highly inefficient.” “This combination makes IMS a leading partner for healthcare organizations in the planning and execution of clinical trials built on an evidence-based foundation,” he added.

IMS Health is a global company providing information, services, and technology for the healthcare industry.

Share
Share

Featured Articles

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma